EPITHERAPEUTICS ApS: Financial statements 2016
CVR: 30523067
EPITHERAPEUTICS ApS (CVR 30523067) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 447,991,928 and a net result of DKK 356,360,799 compared with DKK -17,092,330 the year before. Equity amounted to DKK 396,063,315. The solvency ratio was 100%.
- Gross Profit
- 447,991,928 kr.
- Profit/Loss
- 356,360,799 kr.
- Equity
- 396,063,315 kr.
- Total Assets
- 396,194,315 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 448 mio. | 356.4 mio. | 396.1 mio. | - |
| 2015 | - | -38.7 mio. | -17.1 mio. | 39.7 mio. | 11 |
| 2014 | - | -28.6 mio. | -39.3 mio. | 56 mio. | - |
| 2013 | - | -20.7 mio. | -34.5 mio. | 15.7 mio. | - |
| 2012 | - | -11.9 mio. | -26.6 mio. | -9.1 mio. | - |
How creditworthy is EPITHERAPEUTICS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
As of October 10, 2016, Robin Lynn Washington has left the board of directors of EPITHERAPEUTICS ApS.
As of October 10, 2016, Brett Alan Pletcher has left the board of directors of EPITHERAPEUTICS ApS.
As of October 10, 2016, Thomas Holst Laursen is registered as liquidator of EPITHERAPEUTICS ApS.
As of October 10, 2016, Robin Lynn Washington has stepped down as director of EPITHERAPEUTICS ApS.
As of October 10, 2016, Brett Alan Pletcher has stepped down as director of EPITHERAPEUTICS ApS.
On October 10, 2016, EPITHERAPEUTICS ApS entered liquidation.
EPITHERAPEUTICS ApS has published its annual report for 2015. Gross profit came to DKK -38,726,094, and the net result was DKK -17,092,330.
About EPITHERAPEUTICS ApS
EPITHERAPEUTICS ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2008 and dissolved in 2023. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee. In 2021, the company reported a gross profit of DKK 72,058 and a net result of DKK -21,073,661 compared with DKK -3,028,693 the year before. Equity amounted to DKK 9,205,571.
